Sai Parenteral's Limited (NSE:SAIPARENT)

India · Delayed Price · Currency is INR

506.10

+22.95 (4.75%)

At close: Nov 9, 2026

Market Cap	22.36B
Revenue (ttm)	6.74B +341.6%
Net Income	249.28M +176.5%
EPS	6.07 -46.1%
Shares Out	44.18M
PE Ratio	83.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	282,912
Open	475.80
Previous Close	483.15
Day's Range	472.00 - 519.00
52-Week Range	400.00 - 706.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2026

About Sai Parenteral's

Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals. The compa... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1988

Employees 293

Stock Exchange National Stock Exchange of India

Ticker Symbol SAIPARENT

Full Company Profile

Financial Performance

In fiscal year 2026, Sai Parenteral's's revenue was 3.87 billion, an increase of 137.42% compared to the previous year's 1.63 billion. Earnings were 142.59 million, a decrease of -1.35%.

Financial Statements